The use of chiral (salen)TiCl2 complexes to induce the asymmetric addition of trimethylsilyl cyanide
to aldehydes has been investigated. The complexes are catalytically active at substrate-to-catalyst ratios as
high as 1000:1, and the optimal catalyst (2e) which is derived from (R,R)-1,2-diaminocyclohexane and 3,5-di-tert-butyl-2-hydroxybenzaldehyde produces trimethylsilyl ethers of cyanohydrins with up to 90% enantiomeric
excess at ambient temperature. Water plays a key role in these reactions since under strictly anhydrous conditions
much lower enantiomeric excesses are produced. The role of water has been shown to be to generate dimeric
complexes of the form [(salen)Ti(μ-O)]2 (4) which are the real catalyst precursors. A structure for one of these
complexes (4a derived from (R,R)-1,2-diaminocyclohexane and 2-hydroxybenzaldehyde) has been determined
by X-ray crystallography. The dimeric complexes are more active than the dichloride precursors, and at substrate-to-catalyst ratios between 100 and 1000:1 give cyanohydrin trimethylsilyl ethers with up to 92% enantiomeric
excess in less than 1 h at ambient temperature.
Dedicated to Professor Dieter Seebach on the occasion of his 65th birthdayThe utility of the chiral [Ti(m-O)(salen)] 2 complexes (R)-and (S)-1 (H 2 salen was prepared from (R,R)-or (S,S)-cyclohexane-1,2-diamine and 3,5-di(tert-butyl)-2-hydroxybenzaldehyde) as catalysts for the asymmetric addition of KCN and Ac 2 O to aldehydes to produce O-acetylcyanohydrins was investigated. It was shown that the complexes were active at a substrate/catalyst ratio of 100 : 1 and produced the O-protected cyanohydrins with ee in the range of 60 ± 92% at À 408. Other complexes, [Ti 2 (AcO) 2 (m-O)(salen) 2 ] ((R)-4) and [Ti(CF 3 COO) 2 (salen)] ((R)-5), were prepared from (R)-1 by treatment with different amounts of Ac 2 O and (CF 3 CO) 2 O, and their catalytic activities were tested under the same conditions. The efficiency of (R)-4 was found to be even greater than that of (R)-1, whereas (R)-5 was inactive. The synthesis of the corresponding salen complexes of V IV and V V ,, was elaborated, and their X-ray crystal structures were determined. The efficiency of (R)-3 was sufficient to produce O-acetyl derivatives of aromatic cyanohydrins with ee in the range of 80 ± 91% at À 408.Introduction. ± As enantiomerically pure cyanohydrins are versatile intermediates in organic synthesis, many synthetic approaches to their syntheses are being vigorously pursued [1]. The catalytic ways of making this class of compounds rely upon the asymmetric addition of a cyanide source to the carbonyl group of aldehydes, as catalyzed by enzymes [2] or purely chemical chiral catalysts [3]. Enantiomerically enriched O-protected cyanohydrins are customarily made by the reaction of aldehydes with Me 3 SiCN usually catalyzed by chiral Lewis acids [1]. We recently reported an efficient catalysis of this reaction by the chiral binuclear [Ti IV (salen)] complex 1 (Fig. 1), active at a ratio of substrate/catalyst as high as 1000 : 1 and promoting the addition at room temperature with ee in the range of 80 ± 92% [4]. Very efficient catalysts based on bifunctional complexes of Al III and Ti IV have also been developed by Shibasaki and co-workers, giving O-(trimethylsilyl) derivatives of cyanohydrins with ee as high as 90 ± 99% at À 428 [5].Unfortunately, Me 3 SiCN is an expensive material, and HCN is extremely toxic. Evidently, there is a need to find cheaper and safer initial materials for the synthesis of enantiomerically pure O-protected cyanohydrins. This paper reports the asymmetric synthesis of O-acetylcyanohydrins by the reaction of KCN, acetic anhydride (Ac 2 O),
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.